Thank you for considering participating in the ELAINE-3 study. While your decision is completely voluntary, it can have a real impact on the future of breast cancer treatment. Take the short questionnaire below to see if you may be eligible for the ELAINE-3 study!
Leal is a patient-first digital health company with a mission to democratize access to cancer treatment. Recognized by TIME as one of "The 100 Best Inventions of 2020" and named an honoree in Fast Company's "2021 World Changing Ideas Awards", Leal uses artificial intelligence (AI) to inform and empower people with cancer to own their treatment journey. Leal has helped make over 4.5 million treatment matches and supported more than 160,000 patients on their treatment journeys.
To find your precise personalized treatment options takes between 2-5 minutes:
